The JSE may benefit on Tuesday morning from a surging Tencent and higher Asian markets, amid hopes of a Covid-19 vaccine.
Pfizer and BioNtech announced positive results from their Covid-19 vaccine trial in Germany, which added to the promising results reported earlier this month, National Australia Bank analyst Rodrigo Catril said in a note...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.